These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8398160)

  • 1. Proteolytic cleavage of fibrinogen: amplification of its surfactant inhibitory capacity.
    Seeger W; Grube C; Günther A
    Am J Respir Cell Mol Biol; 1993 Sep; 9(3):239-47. PubMed ID: 8398160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A coagulative type of pulmonary surfactant depletion--a mechanism of damage to the pulmonary surfactant system].
    Koga Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):434-44. PubMed ID: 7927172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant.
    Seeger W; Thede C; Günther A; Grube C
    Biochim Biophys Acta; 1991 Jan; 1081(1):45-52. PubMed ID: 1991155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clot-embedded natural surfactant: kinetics of fibrinolysis and surface activity.
    Günther A; Kalinowski M; Elssner A; Seeger W
    Am J Physiol; 1994 Nov; 267(5 Pt 1):L618-24. PubMed ID: 7977772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity.
    Seeger W; Elssner A; Günther A; Krämer HJ; Kalinowski HO
    Am J Respir Cell Mol Biol; 1993 Aug; 9(2):213-20. PubMed ID: 8338688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant incorporation markedly alters mechanical properties of a fibrin clot.
    Günther A; Kalinowski M; Rosseau S; Seeger W
    Am J Respir Cell Mol Biol; 1995 Dec; 13(6):712-8. PubMed ID: 7576709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants.
    Seeger W; Günther A; Thede C
    Am J Physiol; 1992 Mar; 262(3 Pt 1):L286-91. PubMed ID: 1550251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fibrinogen degradation products and lung ground substance on surfactant function.
    O'Brodovich HM; Weitz JI; Possmayer F
    Biol Neonate; 1990; 57(6):325-33. PubMed ID: 2142607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoprotein-based synthetic surfactants inhibit plasmic cleavage of fibrinogen in vitro.
    Günther A; Bleyl H; Seeger W
    Am J Physiol; 1993 Aug; 265(2 Pt 1):L186-92. PubMed ID: 8368328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity.
    Holm BA; Wang Z; Egan EA; Notter RH
    Pediatr Res; 1996 May; 39(5):805-11. PubMed ID: 8726232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B.
    Palmblad M; Johansson J; Robertson B; Curstedt T
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):381-6. PubMed ID: 10191270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of modified natural surfactant after exposure to fibrinogen in vitro and in an animal model of respiratory distress syndrome.
    Calkovska A; Linderholm B; Haegerstrand-Björkman M; Curstedt T
    Pediatr Res; 2012 Sep; 72(3):262-9. PubMed ID: 22691953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins.
    Friedrich W; Schmalisch G; Stevens PA; Wauer RR
    Eur J Med Res; 2000 Jul; 5(7):277-82. PubMed ID: 10903187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.
    Manalo E; Merritt TA; Kheiter A; Amirkhanian J; Cochrane C
    Pediatr Res; 1996 Jun; 39(6):947-52. PubMed ID: 8725253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy.
    Whitsett JA; Ohning BL; Ross G; Meuth J; Weaver T; Holm BA; Shapiro DL; Notter RH
    Pediatr Res; 1986 May; 20(5):460-7. PubMed ID: 3754957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW; Marder VJ
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of different surfactant preparations to inactivation by meconium.
    Herting E; Rauprich P; Stichtenoth G; Walter G; Johansson J; Robertson B
    Pediatr Res; 2001 Jul; 50(1):44-9. PubMed ID: 11420417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation.
    Schermuly RT; Günther A; Ermert M; Ermert L; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Walmrath D
    Am J Physiol Lung Cell Mol Physiol; 2001 Apr; 280(4):L792-800. PubMed ID: 11238021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.